VYNE

Yarrow Bioscience, Inc.

Healthcare · Biotechnology

$272.37 sample

+4.02 (+1.50%) 1D

Market cap

$586.6B

Price as of

2026-10-03

Latest filing

8-K

Alerts

8

Price$272.37 +15.61% 3M daily closessample

276.47235.60

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 25INSInsider sell: EVP, Operations
Sep 16INSInsider buy: Director
Sep 09INSInsider sell: EVP, Operations
Sep 04INSInsider sell: Director
Sep 01INSInsider buy: Chief Executive Officer
Aug 25INSInsider buy: 10% owner
Aug 17INSInsider sell: EVP, Operations
Aug 06INSInsider sell: Director

Sign up to see the real VYNE record →

Company facts

SEC EDGAR registration

Name: Yarrow Bioscience, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +9sample, -100 to +100
Reporting currency: USD

Who is positioning in VYNE

sample

Insiders: 8 insider transactions over 90 days, net selling, $622.7M
Congress: 2 members traded over 90 days
Institutions · 13F: 42 funds hold $5.7B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$28.4B +23.3% y/y

Q4 2024Q3 2026

Inventory$16.3B +14.5% y/y

Q4 2024Q3 2026

Accounts receivable$12.5B +12.3% y/y

Q4 2024Q3 2026

Total debt$33.3B +15.8% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $551.9B -5.3% 3M
Sample peer B: $231.9B +9.9% 3M
Sample peer C: $458.3B +13.3% 3M
Sample peer D: $454.1B -12.0% 3M
Sample peer E: $242.1B -1.8% 3M